- Home
- PULM vs CENN Comparison
PULM vs CENN Comparison
Compare PULM & CENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- CENN
- Stock Information
- Founded
- PULM 2003
- CENN 2013
- Country
- PULM United States
- CENN United States
- Employees
- PULM N/A
- CENN N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- CENN Auto Manufacturing
- Sector
- PULM Health Care
- CENN Consumer Discretionary
- Exchange
- PULM Nasdaq
- CENN Nasdaq
- Market Cap
- PULM 33.2M
- CENN 30.4M
- IPO Year
- PULM N/A
- CENN N/A
- Fundamental
- Price
- PULM $6.50
- CENN $0.68
- Analyst Decision
- PULM
- CENN
- Analyst Count
- PULM 0
- CENN 0
- Target Price
- PULM N/A
- CENN N/A
- AVG Volume (30 Days)
- PULM 60.7K
- CENN 503.3K
- Earning Date
- PULM 08-12-2025
- CENN 08-12-2025
- Dividend Yield
- PULM N/A
- CENN N/A
- EPS Growth
- PULM N/A
- CENN N/A
- EPS
- PULM N/A
- CENN N/A
- Revenue
- PULM $1,921,000.00
- CENN $31,097,533.00
- Revenue This Year
- PULM N/A
- CENN N/A
- Revenue Next Year
- PULM $134.88
- CENN N/A
- P/E Ratio
- PULM N/A
- CENN N/A
- Revenue Growth
- PULM N/A
- CENN 234.45
- 52 Week Low
- PULM $1.78
- CENN $0.61
- 52 Week High
- PULM $10.40
- CENN $1.84
- Technical
- Relative Strength Index (RSI)
- PULM 39.79
- CENN 40.89
- Support Level
- PULM $6.26
- CENN $0.61
- Resistance Level
- PULM $6.96
- CENN $0.76
- Average True Range (ATR)
- PULM 0.87
- CENN 0.09
- MACD
- PULM -0.12
- CENN -0.02
- Stochastic Oscillator
- PULM 40.16
- CENN 15.60
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About CENN Cenntro Electric Group Limited
Cenntro Inc is a designer, manufacturer, distributor, and service provider of commercial vehicles powered by either electricity or hydrogen energy sources. The company's commercial vehicles are designed to serve a variety of fleet and municipal organizations in support of city services, last-mile delivery, and other commercial applications. It has developed a series of commercial vehicle models, including Metro, Logistar, Logimax, Avantier, Teemak, and Antric One. In addition, the company has introduced an open-platform, programmable all-electric iChassis platform, designed for automated and autonomous driving. Geographically, the company generates maximum revenue from vehicle sales in the United States, and also has a presence in Europe, Asia, and other regions.